project hyperion

No metal.  No graft.  Just liquid.  Stent.

Project brief

Cardiovascular diseases have become one of the most aggressive disciplines that are focused in the world today. Although there have been many advances, from the Jarvik Heart to the stent. The transformation of minimizing collateral damage has made this discipline one of the most targeted areas to innovate.

With the introduction of the first liquid stent. It is a novel take on utilizing a patient’s own cells while meshing toward dynamic synthetics .

Patient Population

Market Innovations

Targeted Indications

Annual Diagnosis

“Heart disease has been transforming since the first diagnosis. As more patients opt out of invasive surgery to find alternative solutions, the need for innovation to fight against aggressive cardiovascular illnesses will increase dramatically.”

Current Study

Currently, in pre-clinical development, Project Hyperion will be advancing toward clinical stages by 2021.

Project Hyperion disease profiles that are currently being targeted under pre-clinical development.

  • <p>Aortic Valve Stenosis</p>
  • <p>Heart Regurgitation</p>
  • <p>Cardiomyopathy</p>

Learn more about project hyperion

“The heart is the only muscle in which we both feel and live simultaneously.”